Scott Tozier
Analyst · Dmitry Silversteyn of Longbow Research. Please go ahead
Thanks Luke, and good morning, everyone. For the second quarter, we reported adjusted earnings per share of $1.13, an increase of $0.20 per share compared to the second quarter of 2016, or 21% growth, excluding the year-over-year impact of divested businesses. Growth in our businesses resulted in an increase of about $0.29. Business results were offset by a net cost increase in other areas of about $0.09 per share, primarily due to increased corporate expenses and a higher effective tax rate compared to second quarter of 2016. Business mix by country and continued strength in our Jordan Bromine Company joint venture drove a favorable effective tax rate in the quarter compared to our previous assumptions. As such, we now expect our full year 2017 effective tax rate, excluding special items, non-operating pension and OPEB items, to be just under 21%, down from prior guidance of 22%. Corporate costs were $28.2 million during the second quarter, driven by professional fees and compensation costs. Given our updated view of the rest of the year, 2017 corporate costs are now likely to reach the upper end of our expected range of $95 million to $105 million. Operating working capital ended the second quarter at 27% of revenue, in line with our 2017 guidance, and we expect to remain at a similar level for the rest of the year. In June, we completed the accelerated share repurchase program initiated in March. In total, we received and retired just over 2.3 million shares and expect our average share counts for all of 2017 to now be about 112.3 million shares. Our share counts for the second half will be 112 million even. We will continue to evaluate capital allocation opportunities between projects and transactions that accelerate our growth strategy and additional share repurchase programs. Capital spending year-to-date through June was $98 million. As Luke noted, our Wave 1 projects are ramping very quickly, and substantial project commitments have been made. This activity should drive increased spending in the second half of 2017. Based on payment terms and timing of equipment delivery, we expect total 2017 CapEx spending to be $325 million the $375 million, slightly lower than our previous guidance. In the first half of the year, our adjusted free cash flow was $170 million. This number represents cash flow from operations, adding back pensions and postretirement contributions, and subtracting capital expenditures, but excluding onetime acquisition and tax related costs. Unadjusted free cash flow, including those onetime costs, was impacted by a one-time tax payment of approximately $255 million, related to the sale of the Chemetall business. For the full year, we anticipate adjusted free cash flow of $225 million to $325 million. Now let me turn to our business units. Lithium and Advanced Materials had a very strong quarter, with net sales of $318 million and adjusted EBITDA of $133 million. This resulted in adjusted EBITDA margins of 42%. Compared to the second quarter of 2016, net sales were up 36% and adjusted EBITDA was up 60%. Let me break down these results a little more. The lithium portfolio again delivered outstanding results. Second quarter net sales were up 55% and adjusted EBITDA up 80% compared to the second quarter of 2016. Adjusted EBITDA margins were 47%, and overall volume grew in the quarter by 25%, with pricing improving by approximately 31%. The results were primarily driven by hydroxide volume growth, produced by our assets in China and by product and customer mix with higher average sales prices. For the full year, we now expect average pricing to be up about 20%. During the first half of 2017, overall global lithium operations have exceeded our expectations. We expect this to allow us to meet our full year target volume growth, while taking prudent steps to optimize brine inventory as we systematically ramp up Chile. Even with higher-than-average rainfall in the Atacama in 2017, our production team has put in place adequate contingency plans that should allow us to meet our stated goal of adding 10,000 metric tons of new LCE production this year. The split of carbonate and hydroxide production may change somewhat from our Q1 forecast, but we will continue to match production needs with the needs of our contracted customers. Full year expectations for adjusted EBITDA and volume both for the Lithium business remain unchanged. We still expect to deliver an adjusted EBITDA increase greater than 35% compared to 2016 and about 10,000 metric tons of growth on LCE basis. Due to product and customer mix and our increasing efforts in lithium resource exploration for Wave 2 growth, our adjusted EBITDA in the third and fourth quarter is expected to be similar to the first quarter of 2017. PCS performed in line with expectations. Net sales were down 2% and adjusted EBITDA was down 6% compared to the second quarter of 2016. Our full year expectation remains unchanged. Second quarter net sales for Bromine Specialties were $204 million, down 1% year-on-year. Adjusted EBITDA was $62 million, down 7%, and was impacted by unfavorable pricing of the byproduct potassium hydroxide, higher freight costs and lower clear brine volumes. Clear brine volumes were particularly strong in second quarter of 2016, providing a difficult comparison. Flame retardant demand across electronics applications continues to be healthy. The business delivered strong adjusted EBITDA margins in the quarter of 30%. Refining Solutions reported second quarter net sales of $184 million, and adjusted EBITDA of $50 million. Compared to the second quarter of 2016, sales were up 3% and adjusted EBITDA was down 19%. Adjusted EBITDA for the second quarter was down as anticipated, driven by sales mix and higher input costs. Sales volumes were supported by solid demand in clean fuel technologies, or HPC catalysts, especially in the heavier feed resid segment. This segment is traditionally lower margin. Fluid catalytic cracking, or FCC catalyst volumes, were down due to customer turnarounds and competitive trials, just as in the first quarter, but were partially offset by strength in FCC volumes in North America where lower margin VGO products are more prominent. Now I'll turn the call back over to Luke to update our view for the year.